Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 5/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | HPN | P05981 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7149136 | 0.93 | CA1 (0.49) | CA2CA1ALDH1A1GAAALOX15 | |
| SCHEMBL17274608 | 0.84 | CA2 (0.67) | CA2CA1PTGS2PTGS1EGFR | |
| SCHEMBL240515 | 0.82 | CA2 (0.80) | CA2CA1PTGS2PTGS1EGFR | |
| SCHEMBL29602570 | 0.82 | CA2 (0.80) | CA2CA1PTGS2PTGS1EGFR | |
| SCHEMBL17285536 | 0.81 | CA1 (0.49) | CA2CA1PTGS2PTGS1ALDH1A1 | |
| SCHEMBL9192342 | 0.81 | CA1 (0.52) | CA2CA1PTGS2PTGS1EGFR | |
| SCHEMBL17270586 | 0.78 | CA1 (0.47) | CA2CA1EGFRVCAM1TNFRSF1A | |
| SCHEMBL13932560 | 0.78 | CA2 (0.59) | CA2CA1PTGS2PTGS1EGFR | |
| SCHEMBL16464356 | 0.78 | CA1 (0.54) | CA2CA1ALDH1A1GAAALOX15 | |
| SCHEMBL17270588 | 0.77 | CA1 (0.57) | CA2CA1EGFRVCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150274627-A1 | BISPHOSPHITE MIXTURE AND USE THEREOF AS A CATALYST MIXTURE IN HYDROFORMYLATION | EVONIK DEGUSSA GMBH (DE) | 2015-10-01 | — | — | US | disclosed |
| US-20090292146-A1 | CATALYST PRECURSOR FOR AN Rh COMPLEX CATALYST | EVONIK OXENO GMBH (DE) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150274627-A1 | BISPHOSPHITE MIXTURE AND USE THEREOF AS A CATALYST MIXTURE IN HYDROFORMYLATION | BPGM, PFKFB4, PFKFB3 | CA2 428/4885CA1 568/4885PTGS2 3349/4885 |
| US-20090292146-A1 | CATALYST PRECURSOR FOR AN Rh COMPLEX CATALYST | RFC2, RFC4, RFC5 | CA2 2429/4885CA1 2020/4885PTGS2 1824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.